Regulation of Angiogenesis by Th1- and Th2-Type Cytokines
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
511-519
Author(s):
A. Naldini, A. Pucci, C. Bernini and F. Carraro
Thrombospondins as Anti-Angiogenic Therapeutic Agents
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
583-588
Author(s):
Bruno Vailhé and Jean-Jacques Feige
Apoptosis in Drug Response
Journal:
Current Pharmacogenomics
Volume:
1
Page:
9-16
Author(s):
Simone Fulda and Klaus-Michael Debatin
New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
119-131
Author(s):
Shinji Osada and Shigetoyo Saji
Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
133-138
Author(s):
Cristiano Ferlini, Iwao Ojima, Mariagrazia Distefano, Daniela Gallo, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Salvatore Mancuso and Giovanni Scambia
subject Index To Volume 2
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
93-94
Author(s):
Bentham Science Publishers
Assessment of Gene Transfer Using Imaging Methodology
Journal:
Current Genomics
Volume:
4
Page:
167-184
Author(s):
Annette Altmann and Uwe Haberkorn
Current Targets for Anticancer Drug Discovery
Journal:
Current Drug Targets
Volume:
4
Page:
159-179
Author(s):
Nguyen-Hai Nam and Keykavous Parang
Neuropeptides as Autocrine Growth Factors in Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
495-509
Author(s):
Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen
Receptor-Based Design of Cytokine Therapeutics
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
1-20
Author(s):
A. B. Shanafelt